Literature DB >> 28314677

Vulvovaginal candidiasis: Etiology, symptomatology and risk factors.

L Mtibaa1, N Fakhfakh2, A Kallel2, S Belhadj2, N Belhaj Salah2, N Bada2, K Kallel2.   

Abstract

OBJECTIVE: To determine epidemiological, clinical and mycological characteristics of vulvovaginal candidiasis (VVC) in Tunisian population and to evaluate predisposing factors. PATIENTS AND METHODS: In this retrospective study, 2160 vaginal swabs were performed over 2 years (January 2014-December 2015). It was carried out at the laboratory of Parasitology and Mycology, Rabta Hospital in Tunisia. After swab collecting, direct examination and culture on Sabouraud Chloramphenicol and Sabouraud Chloramphenicol Actidione media were implemented to research yeasts. Then identifying of yeast species was through chlamydosporulation test and auxanogram. For each patient, a questionnaire was filled noting age, medical and surgical history, symptoms and risk factors. Statistical analysis of data was performed on SPSS 16 using Khi2 test, P<0.05 was considered significant.
RESULTS: Direct examination was positive showed spore and/or pseudohypha in 24.72%. Candida albicans was isolated most frequently (76.61%) followed by Candida glabrata (17.18%). The maximum frequency of Candida-positive cultures was in 25-34 years old age group. Leucorrhea was the most common symptom (72.25%) followed by vulvar prurits (63.23%), dyspareunia (32.25%) and urinary burning (24.92%). Only pregnancy was correlated positively with VVC.
CONCLUSION: It appears from our study that VVC is relatively common in Tunisia. His diagnosis results from confrontation of anamnestic, clinical and mycological data. The knowledge of risk factors and their correction would be necessary to prevent the occurrence of VVC, especially in its recurrent form.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Candida; Candidose vulvovaginale; Facteurs de risque; Risk factors; Tunisia; Tunisie; Vulvovaginal candidiasis

Mesh:

Substances:

Year:  2017        PMID: 28314677     DOI: 10.1016/j.mycmed.2017.01.003

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  6 in total

1.  Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.

Authors:  Nahed Ghaddar; Elie Anastasiadis; Rawad Halimeh; Ali Ghaddar; Rita Dhar; Wadha AlFouzan; Hoda Yusef; Mira El Chaar
Journal:  BMC Infect Dis       Date:  2020-01-13       Impact factor: 3.090

2.  Comparison of the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of vulvovaginal candidiasis.

Authors:  Shirin Jaldani; Mahnaz Fatahinia; Elham Maraghi; Eskandar Moghimipour; Mojgan Javadnoori
Journal:  J Med Life       Date:  2021 Jan-Mar

Review 3.  Prevalence and Risk Factors of Vulvovaginal Candidosis during Pregnancy: A Review.

Authors:  Tasfia Disha; Fahim Haque
Journal:  Infect Dis Obstet Gynecol       Date:  2022-07-20

4.  Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Candida albicans and Non-Candida albicans Species.

Authors:  Faezeh Mohammadi; Nima Hemmat; Zahra Bajalan; Amir Javadi
Journal:  Biomed Res Int       Date:  2021-05-28       Impact factor: 3.411

5.  The characteristics and risk factors of human papillomavirus infection: an outpatient population-based study in Changsha, Hunan.

Authors:  Dabao Xu; Xingping Zhao; Bingsi Gao; Yu-Ligh Liou; Yang Yu; Lingxiao Zou; Waixing Li; Huan Huang; Aiqian Zhang
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

6.  Evaluating the accuracy and diagnostic value of CFW and a new fluorescent reagents, fluorescent brightener 85, for the diagnosis of vulvovaginal candidiasis.

Authors:  Yunzhuan Zhao; Zixuan Yu; Xueping Yue
Journal:  J Clin Lab Anal       Date:  2021-07-12       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.